-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
- Reviva Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $359K, a 86.3% decline year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.47M, a 47% decline year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.41M, a 1831% increase from 2022.
- Reviva Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $177K, a 65.6% increase from 2021.
- Reviva Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $107K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)